JP3332171B2 - Method for producing thieno [3,2-b] pyridine derivative - Google Patents

Method for producing thieno [3,2-b] pyridine derivative

Info

Publication number
JP3332171B2
JP3332171B2 JP15235793A JP15235793A JP3332171B2 JP 3332171 B2 JP3332171 B2 JP 3332171B2 JP 15235793 A JP15235793 A JP 15235793A JP 15235793 A JP15235793 A JP 15235793A JP 3332171 B2 JP3332171 B2 JP 3332171B2
Authority
JP
Japan
Prior art keywords
group
acid
general formula
thieno
following general
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP15235793A
Other languages
Japanese (ja)
Other versions
JPH0710880A (en
Inventor
英一郎 岩下
茂 小川
明子 木原
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Chemical Corp
Original Assignee
Mitsubishi Chemical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Chemical Corp filed Critical Mitsubishi Chemical Corp
Priority to JP15235793A priority Critical patent/JP3332171B2/en
Publication of JPH0710880A publication Critical patent/JPH0710880A/en
Application granted granted Critical
Publication of JP3332171B2 publication Critical patent/JP3332171B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/52Improvements relating to the production of bulk chemicals using catalysts, e.g. selective catalysts

Landscapes

  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【産業上の利用分野】本発明は、抗菌活性または抗高血
圧活性等を有する医薬品として有用なチエノ〔3,2−
b〕ピリジンカルボン酸誘導体またはその中間体である
チエノ〔3,2−b〕ピリジン誘導体を製造する方法に
関する。
The present invention relates to a thieno [3,2-) useful as a pharmaceutical having antibacterial activity or antihypertensive activity.
b] A method for producing a pyridinecarboxylic acid derivative or an intermediate thereof, a thieno [3,2-b] pyridine derivative.

【0002】[0002]

【従来の技術および発明が解決しようとする課題】下記
一般式(III )
2. Description of the Related Art The following general formula (III)

【0003】[0003]

【化3】 Embedded image

【0004】(上記式中で、R6 およびR7 はそれぞれ
独立して水素原子、ハロゲン原子、C1 〜C6 のアルキ
ル基等を表し、R8 は水酸基、C1 〜C6 のアルコキシ
基またはアミノ基等を表し、R9 はC1 〜C6 のアルキ
ル基等を表す)で表されるチエノ〔3,2−b〕ピリジ
ンカルボン酸誘導体は抗菌活性(特開昭57−4269
0号公報)または抗高血圧活性(欧州特許第02692
95号)を有することが知られている。
(In the above formula, R 6 and R 7 each independently represent a hydrogen atom, a halogen atom, a C 1 -C 6 alkyl group, etc., R 8 represents a hydroxyl group, a C 1 -C 6 alkoxy group. Or a thieno [3,2-b] pyridinecarboxylic acid derivative represented by an amino group or the like, and R 9 represents a C 1 -C 6 alkyl group or the like;
No. 0) or antihypertensive activity (European Patent No. 02692)
No. 95).

【0005】前記一般式(III )で表されるチエノ
〔3,2−b〕ピリジンカルボン酸誘導体は、下記一般
式(II)で表されるチエノ〔3,2−b〕ピリジン誘導
体を一般に知られている方法、例えばC1 〜C6 のアル
コキシカルボニル基またはシアノ基を、酸あるいはアル
カリの存在下に加水分解することにより対応するカルボ
ン酸に誘導する方法、カルボン酸にアンモニア等のアミ
ン類を反応させてカルボキサミドに誘導する方法またR
3 が水素原子の場合は、K2 CO3 等の塩基の存在下に
DMF等の溶媒中で適当なアルキル基を有するハロゲン
化アルキルと反応させることによるピリジン環のN−ア
ルキル化体の合成法等を、それぞれ単独または組み合わ
せて用いることにより、合成されてきた(Richar
d L.Elliott et al.,Tetrah
edron Vol.43,No.14,pp3295
to 3302,1987、欧州特許第026929
5号、特開昭57−42690号公報、特開昭57−1
16077号公報、特開昭57−142985号公
報)。
The thieno [3,2-b] pyridinecarboxylic acid derivative represented by the general formula (III) is generally known as a thieno [3,2-b] pyridine derivative represented by the following general formula (II). For example, a method of deriving a corresponding carboxylic acid by hydrolyzing a C 1 -C 6 alkoxycarbonyl group or a cyano group in the presence of an acid or an alkali, and adding an amine such as ammonia to the carboxylic acid. Reaction to induce carboxamide or R
When 3 is a hydrogen atom, a method for synthesizing an N-alkylated pyridine ring by reacting with an alkyl halide having an appropriate alkyl group in a solvent such as DMF in the presence of a base such as K 2 CO 3 And the like have been synthesized alone or in combination (Richard
d L. Elliott et al. , Tetrah
edron Vol. 43, no. 14, pp3295
to 3302, 1987, EP 026929.
5, JP-A-57-42690, JP-A-57-1
No. 16077, JP-A-57-142985).

【0006】即ち下記一般式(II)の化合物は、医薬品
として有用な前記一般式(III )の化合物、または前記
一般式(III )の化合物を合成するための有用な合成中
間体である。下記一般式(II)で表されるチエノ〔3,
2−b〕ピリジン誘導体は、下記一般式(I)で表され
るN−チエニルアミノメチレン酢酸誘導体を、一般にG
ould−Jacobs法として知られている方法、例
えばDowtherm A、ジフェニルまたはジフェニ
ルエーテル等の高沸点溶媒中、200〜260℃で加熱
する方法(Richard L.Elliott et
al.,Tetrahedron Vol.43,N
o.14,pp3295 to 3302,1987)
で合成されることが知られているが、この方法では20
0〜260℃という高温を必要とするため工業的に用い
るには大きな制約を受ける等の問題点がある。
That is, the compound of the following general formula (II) is a compound of the above general formula (III) useful as a pharmaceutical or a synthetic intermediate useful for synthesizing the compound of the above general formula (III). Thieno [3, represented by the following general formula (II)
2-b] pyridine derivative is an N-thienylaminomethylene acetic acid derivative represented by the following general formula (I);
a method known as the Old-Jacobs method, for example, a method of heating at 200 to 260 ° C. in a high boiling point solvent such as Dowtherm A, diphenyl or diphenyl ether (Richard L. Elliott et al.)
al. , Tetrahedron Vol. 43, N
o. 14, pp3295 to 3302, 1987)
Is known to be synthesized by this method.
Since a high temperature of 0 to 260 ° C. is required, there is a problem that industrial use is greatly restricted.

【0007】また下記一般式(II)で表されるチエノ
〔3,2−b〕ピリジン誘導体は、下記一般式(I)で
表されるN−チエニルアミノメチレン酢酸誘導体を、オ
キシ塩化リン、オキシ臭化リン、五塩化リン、五臭化リ
ン、三塩化リン、三臭化リン、チオニルクロライド、チ
オニルブロマイド等の含ハロゲン酸性物質を80〜14
0℃で作用させる方法(特開昭57−42690号公
報)により合成されることが知られているが、下記一般
式(I)で表される化合物のうち、R1 が臭素原子、R
2 およびR3 が水素原子に限定された化合物以外例がな
く、また得られる閉環体は7位がハロゲン化されている
上、用いる含ハロゲン酸性物質のハロゲン原子が臭素原
子と一部置換したものとの混合物であるため、その応用
範囲にはおのずと限界がある。
A thieno [3,2-b] pyridine derivative represented by the following general formula (II) is obtained by converting an N-thienylaminomethylene acetic acid derivative represented by the following general formula (I) to phosphorus oxychloride, 80 to 14 halogen-containing acidic substances such as phosphorus bromide, phosphorus pentachloride, phosphorus pentabromide, phosphorus trichloride, phosphorus tribromide, thionyl chloride and thionyl bromide.
It is known that the compound is synthesized by a method of acting at 0 ° C. (JP-A-57-42690). Among the compounds represented by the following general formula (I), R 1 is a bromine atom,
There are no examples other than compounds in which 2 and R 3 are limited to hydrogen atoms, and the obtained ring-closed product is one in which the 7-position is halogenated and the halogen atom of the halogen-containing acidic substance used is partially substituted with a bromine atom. Since it is a mixture with, its application range is naturally limited.

【0008】また下記一般式(II)で表されるチエノ
〔3,2−b〕ピリジン誘導体の合成法として、下記一
般式(I)で表されるN−チエニルアミノメチレン酢酸
誘導体を、ポリリン酸またはポリリン酸エステル中、5
0〜150℃(通常は120℃前後)で加熱する方法
(G Malicorne et al.,Eur J
Med Chem(1991)26,3−11、特開昭
57−116077号公報)が知られているが、ポリリ
ン酸およびポリリン酸エステルは粘稠性物質であり、工
業的製造において制約を受ける。
Further, as a method for synthesizing a thieno [3,2-b] pyridine derivative represented by the following general formula (II), an N-thienylaminomethylene acetic acid derivative represented by the following general formula (I) is synthesized by using polyphosphoric acid. Or 5 in polyphosphate ester
A method of heating at 0 to 150 ° C. (usually around 120 ° C.) (G Malicone et al., Eur J
Med Chem (1991) 26, 3-11, JP-A-57-116077) is known, but polyphosphoric acid and polyphosphate are viscous substances and are restricted in industrial production.

【0009】また、下記の化合物(IV)を、無水酢酸に
加えた後、濃硫酸を加えることによって、ニトロ基の脱
離を伴いながら室温〜70℃(特に55〜70℃)の温
度で閉環し、下記の化合物(V)に導く方法が知られて
いる(石崎孝義ら、日本化学会誌、1985、(1
0)、p.2054〜2056)が、
Further, the following compound (IV) is added to acetic anhydride, and then concentrated sulfuric acid is added to cause ring closure at a temperature of room temperature to 70 ° C. (especially 55 to 70 ° C.) while eliminating nitro groups. A method for deriving the following compound (V) is also known (Takayoshi Ishizaki et al., The Chemical Society of Japan, 1985, (1)
0), p. 2054-2056),

【0010】[0010]

【化4】 Embedded image

【0011】下記一般式(I)で表されるN−チエニル
アミノメチレン酢酸誘導体から下記一般式(II)で表さ
れるチエノ〔3,2−b〕ピリジン誘導体を50℃未満
の緩和な条件下で、得る方法についてはこれまで全く知
られていなかった。
A thieno [3,2-b] pyridine derivative represented by the following general formula (II) is converted from an N-thienylaminomethyleneacetic acid derivative represented by the following general formula (I) under a mild condition of less than 50 ° C. So far, how to obtain it was not known at all.

【0012】[0012]

【課題を解決するための手段】本発明者らは、前記の課
題に鑑み検討を重ねた結果、下記一般式(I)で表され
るN−チエニルアミノメチレン酢酸誘導体を、濃硫酸等
の無機酸の存在下、無水酢酸等の有機酸の酸無水物中、
比較的低温度で反応させるという緩和な条件のもとで下
記一般式(II)で表されるチエノ〔3,2−b〕ピリジ
ン誘導体が得られることを見い出し本発明を完成するに
至った。
Means for Solving the Problems As a result of repeated studies in view of the above problems, the present inventors have found that an N-thienylaminomethylene acetic acid derivative represented by the following general formula (I) can be converted into an inorganic compound such as concentrated sulfuric acid. In the presence of an acid, in an acid anhydride of an organic acid such as acetic anhydride,
The present inventors have found that a thieno [3,2-b] pyridine derivative represented by the following general formula (II) can be obtained under mild conditions of reacting at a relatively low temperature, and have completed the present invention.

【0013】即ち本発明の要旨は、下記一般式(I)That is, the gist of the present invention is the following general formula (I):

【0014】[0014]

【化5】 Embedded image

【0015】(上記式中で、R1 およびR2 はそれぞれ
独立して水素原子、ハロゲン原子、C1 〜C6 のアルキ
ル基、置換基を有してもよいフェニル基もしくはナフチ
ル基、C1 〜C6 のアルキルスルホニル基またはシアノ
基を表し、R3 は水素原子またはC1 〜C6 のアルキル
基を表し、R4 はC1 〜C6 のアルキル基を表し、R 5
はC1 〜C6 のアルコキシカルボニル基またはシアノ基
を表す。)で表されるN−チエニルアミノメチレン酢酸
誘導体を無機酸の存在下、有機酸の酸無水物中で反応さ
せることを特徴とする下記一般式(II)
(In the above formula, R1And RTwoAre each
Independently a hydrogen atom, a halogen atom, C1~ C6Archi
Group, phenyl group which may have a substituent or naphthyl
Group, C1~ C6Alkylsulfonyl group or cyano
R represents a groupThreeIs a hydrogen atom or C1~ C6The alkyl of
R represents a groupFourIs C1~ C6Represents an alkyl group of Five
Is C1~ C6An alkoxycarbonyl group or a cyano group
Represents N-thienylaminomethylene acetic acid represented by
The derivative is reacted in the anhydride of an organic acid in the presence of an inorganic acid.
The following general formula (II):

【0016】[0016]

【化6】 Embedded image

【0017】(上記式中で、R1 ,R2 ,R3 およびR
5 は上記一般式(I)で定義したとおりである。)で表
されるチエノ〔3,2−b〕ピリジン誘導体の製造方法
に存する。以下、本発明について詳細に説明する。前記
一般式(I)および(II)で表される化合物において、
1 およびR2 で定義されるハロゲン原子としては塩素
原子、臭素原子、ヨウ素原子等が挙げられ、C1 〜C6
のアルキル基としてはメチル基、エチル基、n−プロピ
ル基、iso−プロピル基、n−ブチル基、iso−ブ
チル基、sec−ブチル基、tert−ブチル基、n−
ペンチル基、n−ヘキシル基等が挙げられ、置換基を有
してもよいフェニル基としてはフェニル基、パラ−クロ
ロフェニル基、パラ−メチルフェニル基等が挙げられ、
置換基を有していてもよいナフチル基としては1−ナフ
チル基、2−ナフチル基、5−クロロ−1−ナフチル
基、6−メチル−2−ナフチル基等が挙げられ、C1
6 のアルキルスルホニル基としてはメチルスルホニル
基、n−プロピルスルホニル基、iso−プロピルスル
ホニル基等が挙げられる。
(In the above formula, R 1 , R 2 , R 3 and R
5 is as defined in the above general formula (I). The present invention relates to a method for producing a thieno [3,2-b] pyridine derivative represented by the following formula: Hereinafter, the present invention will be described in detail. In the compounds represented by the general formulas (I) and (II),
Examples of the halogen atom defined by R 1 and R 2 include a chlorine atom, a bromine atom and an iodine atom, and C 1 -C 6
Examples of the alkyl group of methyl, ethyl, n-propyl, iso-propyl, n-butyl, iso-butyl, sec-butyl, tert-butyl, n-
Pentyl group, n-hexyl group and the like, and the phenyl group which may have a substituent include a phenyl group, a para-chlorophenyl group, a para-methylphenyl group, and the like;
The naphthyl group which may have a substituent 1-naphthyl, 2-naphthyl, 5-chloro-1-naphthyl group, 6-methyl-2-naphthyl group and the like, C 1 ~
Alkylsulfonyl As the group methylsulfonyl group of C 6, n-propylsulfonyl group, etc. iso- propylsulfonyl group.

【0018】前記一般式(I)および(II)で表される
化合物においてR3 で定義されるC 1 〜C6 のアルキル
基としてはメチル基、エチル基、n−プロピル基、is
o−プロピル基、n−ブチル基、iso−ブチル基、s
ec−ブチル基、tert−ブチル基、n−ペンチル
基、n−ヘキシル基等が挙げられる。前記一般式(I)
で表される化合物においてR4 で定義されるC1 〜C6
のアルキル基としてはメチル基、エチル基、n−プロピ
ル基、iso−プロピル基、n−ブチル基、iso−ブ
チル基、sec−ブチル基、tert−ブチル基、n−
ペンチル基、n−ヘキシル基等が挙げられる。
The compounds represented by the above general formulas (I) and (II)
In compounds, RThreeC defined by 1~ C6The alkyl of
As the group, a methyl group, an ethyl group, an n-propyl group, is
o-propyl group, n-butyl group, iso-butyl group, s
ec-butyl group, tert-butyl group, n-pentyl
Group, n-hexyl group and the like. Formula (I)
In the compound represented byFourC defined by1~ C6
Examples of the alkyl group include methyl, ethyl, n-propyl
Group, iso-propyl group, n-butyl group, iso-butyl
Tyl group, sec-butyl group, tert-butyl group, n-
Examples include a pentyl group and an n-hexyl group.

【0019】前記一般式(I)および(II)で表される
化合物においてR5 で定義されるC 1 〜C6 のアルコキ
シカルボニル基としてはメトキシカルボニル基、エトキ
シカルボニル基、n−プロポキシカルボニル基、iso
−プロポキシカルボニル基、n−ブトキシカルボニル
基、iso−ブトキシカルボニル基、sec−ブトキシ
カルボニル基、tert−ブトキシカルボニル基等が挙
げられる。
Represented by the above general formulas (I) and (II)
In compounds, RFiveC defined by 1~ C6Alcoqui
Examples of the carbonyl group include a methoxycarbonyl group and an ethoxy group.
Sicarbonyl group, n-propoxycarbonyl group, iso
-Propoxycarbonyl group, n-butoxycarbonyl
Group, iso-butoxycarbonyl group, sec-butoxy
Carbonyl group, tert-butoxycarbonyl group and the like.
I can do it.

【0020】本発明の製造工程を以下に示す。The manufacturing process of the present invention will be described below.

【0021】[0021]

【化7】 Embedded image

【0022】(上記式中で、R1 ,R2 ,R3 ,R4
よびR5 は前記定義と同じ。) まず濃硫酸、過塩素酸等の無機酸、好ましくは濃硫酸
を、酢酸、プロピオン酸等の有機酸の酸無水物、好まし
くは無水酢酸に、−20〜40℃、好ましくは0〜30
℃で加える(工程A)。これに前記一般式(I)の化合
物を加え、50℃未満の温度、好ましくは20〜40℃
で、反応時間は1時間〜72時間、好ましくは2時間〜
24時間で反応させる(工程B)ことにより、前記一般
式(II)で表される化合物を得ることができる。なお本
工程においては、必要ならばTLCまたはHPLC等の
通常の分析方法を用いて工程の分析が可能である。な
お、前記一般式(I)で表される化合物は試薬として販
売されているものを購入して使用することもできるが、
Tetrahedron,43(14),3295(1
987)、特開昭57−116077号公報、欧州特許
第0269295号公報、J.Heterocycli
c Chem.,14,807(1977)、特願平5
−145067号等に記載の方法に従って適宜合成する
こともできる。
(In the above formula, R 1 , R 2 , R 3 , R 4 and R 5 are the same as defined above.) First, an inorganic acid such as concentrated sulfuric acid or perchloric acid, preferably concentrated sulfuric acid is converted to acetic acid, An acid anhydride of an organic acid such as propionic acid, preferably acetic anhydride, is added at -20 to 40 ° C, preferably 0 to 30 ° C.
C. (Step A). The compound of the general formula (I) is added thereto, and the temperature is lower than 50 ° C, preferably 20 to 40 ° C.
And the reaction time is from 1 hour to 72 hours, preferably from 2 hours to
By reacting for 24 hours (step B), the compound represented by the general formula (II) can be obtained. In this step, if necessary, the analysis of the step can be performed by using an ordinary analysis method such as TLC or HPLC. The compound represented by the general formula (I) can be purchased and used as a reagent,
Tetrahedron, 43 (14), 3295 (1
987), JP-A-57-116077, EP 0269295, and J. Heterocyclic
c Chem. , 14 , 807 (1977);
It can also be appropriately synthesized according to the method described in JP-A-145067.

【0023】以上のようにして得られた前記一般式(I
I)で表されるチエノ〔3,2−b〕ピリジン誘導体
は、公知の分離精製手段、例えば濾取、濃縮、抽出、ク
ロマトグラフィー、再沈殿、再結晶等の手段を適宜使用
することによって任意の純度のものとして単離できる。
かくして抗菌剤または抗高血圧剤などの医薬品として有
用な、チエノ〔3,2−b〕ピリジンカルボン酸誘導体
またはその合成中間体として有用なチエノ〔3,2−
b〕ピリジン誘導体を緩和な反応条件下で得ることが出
来る。
The general formula (I) obtained as described above
The thieno [3,2-b] pyridine derivative represented by I) can be arbitrarily prepared by appropriately using known separation and purification means such as filtration, concentration, extraction, chromatography, reprecipitation, and recrystallization. Can be isolated.
Thus, thieno [3,2-b] pyridinecarboxylic acid derivatives useful as pharmaceuticals such as antibacterial agents or antihypertensive agents or thieno [3,2- useful as synthetic intermediates thereof]
b) A pyridine derivative can be obtained under mild reaction conditions.

【0024】[0024]

【発明の効果】本発明の方法に従い、緩和な反応条件下
のもとN−チエニルアミノメチレン酢酸誘導体から、抗
菌剤または抗高血圧剤などの医薬品として有用なチエノ
〔3,2−b〕ピリジンカルボン酸誘導体またはその合
成中間体であるチエノ〔3,2−b〕ピリジン誘導体を
得ることが出来る。
According to the method of the present invention, a thieno [3,2-b] pyridinecarboxylic acid useful as a medicament such as an antibacterial agent or an antihypertensive agent can be produced from an N-thienylaminomethyleneacetic acid derivative under mild reaction conditions. An thieno [3,2-b] pyridine derivative which is an acid derivative or a synthetic intermediate thereof can be obtained.

【0025】[0025]

【実施例】以下に実施例を挙げて本発明を説明するが、
本発明は、これら実施例により何ら限定されるものでは
ない。 合成例1 3−(2,2−ジエトキシカルボニルエテニル)アミノ
チオフェン(前記一般式(I)中、R1 ,R2 およびR
3 が水素原子、R5 がエトキシカルボニル基、R4 がエ
チル基で表される化合物)の合成 水酸化ナトリウム11.2g(282.7ミリモル)
を、水340mlに溶解し、これに3−アミノチオフェ
ン−2−カルボン酸メチルエステル40.4g(257
ミリモル)を加え、30分間加熱還流した。反応液を、
室温まで冷却した後エタノール400mlを加え、更に
酢酸17.7ml(308.4ミリモル)を1時間かけ
て滴下した。滴下終了後更に1時間撹拌してHPLC分
析(カラム:Novapak ODS、移動相:水/メ
タノール/トリエチルアミン=20/80/0.4、流
速:0.8ml/min)にて脱アルコキシカルボニル
体(3−アミノチオフェン)の生成を確認し、これにエ
トキシメチレンマロン酸ジエチルエステル61g(28
2.7ミリモル)を加え、室温で1時間撹拌した。反応
液に水600mlを加え、室温で1時間撹拌した後に析
出した結晶を濾取し、目的化合物3−(2,2−ジエト
キシカルボニルエテニル)アミノチオフェン61.3g
(収率89.0%)を得た。
EXAMPLES The present invention will be described below with reference to examples.
The present invention is not limited by these examples. Synthesis Example 1 3- (2,2-diethoxycarbonylethenyl) aminothiophene (in the above general formula (I), R 1 , R 2 and R
3 is a hydrogen atom, R 5 is an ethoxycarbonyl group and R 4 is an ethyl group) Synthesis of sodium hydroxide 11.2 g (282.7 mmol)
Was dissolved in 340 ml of water, and 40.4 g of methyl 3-aminothiophene-2-carboxylate (257 g) was added thereto.
Mmol), and the mixture was heated under reflux for 30 minutes. The reaction solution is
After cooling to room temperature, 400 ml of ethanol was added, and 17.7 ml (308.4 mmol) of acetic acid was further added dropwise over 1 hour. After completion of the dropwise addition, the mixture was further stirred for 1 hour, and subjected to HPLC analysis (column: Novapak ODS, mobile phase: water / methanol / triethylamine = 20/80 / 0.4, flow rate: 0.8 ml / min) to remove the dealkoxycarbonyl compound (3). -Aminothiophene) was confirmed, and 61 g of ethoxymethylenemalonic acid diethyl ester (28 g
(2.7 mmol) and stirred at room temperature for 1 hour. After adding 600 ml of water to the reaction solution and stirring at room temperature for 1 hour, the precipitated crystals were collected by filtration and 61.3 g of the target compound 3- (2,2-diethoxycarbonylethenyl) aminothiophene.
(89.0% yield).

【0026】m.p. :80−82℃ IR(KBr)cm-1 :3443、1684、163
6、1603、1267、1238 NMR(CDCl3 )δ:1.26〜1.41(6H,
m)、4.18〜4.35(4H,m)、6.86(1
H,d)、6.99(1H,d)、7.33(1H,d
d)、8.39(1H,d)、11.03(1H,d)
M. p. : 80-82 ° C IR (KBr) cm -1 : 3443, 1684, 163
6, 1603, 1267, 1238 NMR (CDCl 3 ) δ: 1.26 to 1.41 (6H,
m), 4.18 to 4.35 (4H, m), 6.86 (1
H, d), 6.99 (1H, d), 7.33 (1H, d)
d), 8.39 (1H, d), 11.03 (1H, d)

【0027】実施例1 7−ヒドロキシチエノ〔3,2−b〕ピリジン−6−カ
ルボン酸エチルエステル(前記一般式(II)において、
1 ,R2 およびR3 は水素原子およびR5 はエトキシ
カルボニル基で表される化合物)の合成 濃硫酸687mg(7.0ミリモル)を無水酢酸9.2
mlに0〜30℃で滴下する。これに20℃で3−
(2,2−ジエトキシカルボニルエテニル)アミノチオ
フェン1.0g(3.7ミリモル)を加え、20℃で1
5時間撹拌した。反応液を氷120gに注ぎ込み、撹拌
下炭酸カリウム14.7gを少しずつ加えた後、クロロ
ホルムにて3回抽出した。クロロホルム層を合わせて、
硫酸マグネシウムで乾燥した後、溶媒を減圧下に留去し
た。得られた残渣にジエチルエーテル10mlを加え撹
拌して、析出した結晶を濾取し、目的化合物である7−
ヒドロキシチエノ〔3,2−b〕ピリジン−6−カルボ
ン酸エチルエステル316mg(収率38.3%)を得
た。
Example 1 7-Hydroxythieno [3,2-b] pyridine-6-carboxylic acid ethyl ester (in the above formula (II),
Synthesis of R 1 , R 2 and R 3 are a hydrogen atom and R 5 is a compound represented by an ethoxycarbonyl group) 687 mg (7.0 mmol) of concentrated sulfuric acid was added to acetic anhydride 9.2.
Add dropwise at 0-30 ° C to the ml. At 20 ° C
1.0 g (3.7 mmol) of (2,2-diethoxycarbonylethenyl) aminothiophene was added and
Stir for 5 hours. The reaction solution was poured into 120 g of ice, 14.7 g of potassium carbonate was added little by little with stirring, and extracted three times with chloroform. Combine the chloroform layers,
After drying over magnesium sulfate, the solvent was distilled off under reduced pressure. 10 ml of diethyl ether was added to the obtained residue, and the mixture was stirred. The precipitated crystals were collected by filtration, and the target compound, 7-
316 mg (yield 38.3%) of hydroxythieno [3,2-b] pyridine-6-carboxylic acid ethyl ester was obtained.

【0028】 m.p. :205−208℃ IR(KBr)cm-1 :3061、1697、164
0、1606、1281 NMR(CDCl3 )δ:1.28(3H,t)、4.
22(2H,q)、7.31(1H,d)、8.05
(1H,d)、8.50(1H,s)、12.80(1
H,broad s)
M. p. : 205-208 ° C IR (KBr) cm -1 : 3061, 1697, 164
0, 1606, 1281 NMR (CDCl 3 ) δ: 1.28 (3H, t);
22 (2H, q), 7.31 (1H, d), 8.05
(1H, d), 8.50 (1H, s), 12.80 (1
H, broad s)

【0029】実施例2 7−ヒドロキシチエノ〔3,2−b〕ピリジン−6−カ
ルボン酸エチルエステル(前記一般式(II)において、
1 ,R2 およびR3 は水素原子およびR5 はエトキシ
カルボニル基で表される化合物)の合成 濃硫酸29.1g(296.5ミリモル)を無水酢酸1
20.0mlに0〜30℃で滴下する。これに10℃で
3−(2,2−ジエトキシカルボニルエテニル)アミノ
チオフェン20.0g(74.0ミリモル)を加え、4
0℃で2.5時間撹拌した。反応液を水2000mlに
注ぎ込み、2時間撹拌した。析出した結晶を濾取し、さ
らに、濾液をクロロホルムにて2回抽出した。抽出した
クロロホルム層を合わせて、硫酸マグネシウムで乾燥し
た後、溶媒を減圧下に留去した。得られた残渣にエタノ
ール60mlを加え撹拌して、析出した結晶を濾取し、
先の結晶と合わせて目的化合物である7−ヒドロキシチ
エノ〔3,2−b〕ピリジン−6−カルボン酸エチルエ
ステル8.70g(収率52.7%)を得た。
Example 2 7-Hydroxythieno [3,2-b] pyridine-6-carboxylic acid ethyl ester (in the above formula (II),
Synthesis of R 1 , R 2 and R 3 are a hydrogen atom and R 5 is a compound represented by an ethoxycarbonyl group) 29.1 g (296.5 mmol) of concentrated sulfuric acid was added to acetic anhydride 1
Add dropwise to 20.0 ml at 0-30 ° C. To this was added 20.0 g (74.0 mmol) of 3- (2,2-diethoxycarbonylethenyl) aminothiophene at 10 ° C.
Stirred at 0 ° C. for 2.5 hours. The reaction solution was poured into 2000 ml of water and stirred for 2 hours. The precipitated crystals were collected by filtration, and the filtrate was extracted twice with chloroform. After the extracted chloroform layers were combined and dried over magnesium sulfate, the solvent was distilled off under reduced pressure. 60 ml of ethanol was added to the obtained residue and the mixture was stirred, and the precipitated crystals were collected by filtration.
8.70 g (yield 52.7%) of 7-hydroxythieno [3,2-b] pyridine-6-carboxylic acid ethyl ester, which is the target compound, was obtained by combining the crystals.

───────────────────────────────────────────────────── フロントページの続き (56)参考文献 特開 昭57−116077(JP,A) 特開 昭57−42690(JP,A) 特開 昭59−219288(JP,A) 特開 昭63−141984(JP,A) Tetrahedron,1987年,V ol.43,No.14,P.3295−3302 J.Chem.Research (M),1982年,P.1726−1746 J.Chem.Research (M),1978年,P.4701−4712 Eur.J.Med.Chem., 1991年,Vol.26,No.1,P.3 −11 (58)調査した分野(Int.Cl.7,DB名) C07D 495/04 105 CA(STN) REGISTRY(STN)──────────────────────────────────────────────────続 き Continuation of front page (56) References JP-A-57-116077 (JP, A) JP-A-57-42690 (JP, A) JP-A-59-219288 (JP, A) JP-A-63-1988 141984 (JP, A) Tetrahedron, 1987, Vol. 43, No. 14, p. 3295-3302 J.P. Chem. Research (M), 1982, p. 1726-1746 J.P. Chem. Research (M), 1978, p. 4701-4712 Eur. J. Med. Chem. , 1991, Vol. 26, No. 1, P. 3-11 (58) Field surveyed (Int. Cl. 7 , DB name) C07D 495/04 105 CA (STN) REGISTRY (STN)

Claims (1)

(57)【特許請求の範囲】(57) [Claims] 【請求項1】 下記一般式(I) 【化1】 (上記式中で、R1 およびR2 はそれぞれ独立して水素
原子、ハロゲン原子、C1 〜C6 のアルキル基、置換基
を有してもよいフェニル基もしくはナフチル基、C1
6 のアルキルスルホニル基またはシアノ基を表し、R
3 は水素原子またはC1 〜C6 のアルキル基を表し、R
4 はC1 〜C6 のアルキル基を表し、R 5 はC1 〜C6
のアルコキシカルボニル基またはシアノ基を表す。)で
表されるN−チエニルアミノメチレン酢酸誘導体を無機
酸の存在下、有機酸の酸無水物中で反応させることを特
徴とする下記一般式(II) 【化2】 (上記式中で、R1 ,R2 ,R3 およびR5 は上記一般
式(I)で定義したとおりである。)で表されるチエノ
〔3,2−b〕ピリジン誘導体の製造方法。
1. A compound represented by the following general formula (I)(In the above formula, R1And RTwoAre each independently hydrogen
Atom, halogen atom, C1~ C6Alkyl group and substituent
A phenyl or naphthyl group optionally having1~
C6Represents an alkylsulfonyl group or a cyano group of
ThreeIs a hydrogen atom or C1~ C6Represents an alkyl group of
FourIs C1~ C6Represents an alkyl group of FiveIs C1~ C6
Represents an alkoxycarbonyl group or a cyano group. )so
An N-thienylaminomethyleneacetic acid derivative represented by an inorganic
The reaction is performed in the presence of an acid in an acid anhydride of an organic acid.
The following general formula (II):(In the above formula, R1, RTwo, RThreeAnd RFiveIs the above general
As defined in formula (I). ) Represented by)
[3,2-b] A method for producing a pyridine derivative.
JP15235793A 1993-06-23 1993-06-23 Method for producing thieno [3,2-b] pyridine derivative Expired - Fee Related JP3332171B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP15235793A JP3332171B2 (en) 1993-06-23 1993-06-23 Method for producing thieno [3,2-b] pyridine derivative

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP15235793A JP3332171B2 (en) 1993-06-23 1993-06-23 Method for producing thieno [3,2-b] pyridine derivative

Publications (2)

Publication Number Publication Date
JPH0710880A JPH0710880A (en) 1995-01-13
JP3332171B2 true JP3332171B2 (en) 2002-10-07

Family

ID=15538780

Family Applications (1)

Application Number Title Priority Date Filing Date
JP15235793A Expired - Fee Related JP3332171B2 (en) 1993-06-23 1993-06-23 Method for producing thieno [3,2-b] pyridine derivative

Country Status (1)

Country Link
JP (1) JP3332171B2 (en)

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
Eur.J.Med.Chem.,1991年,Vol.26,No.1,P.3−11
J.Chem.Research(M),1978年,P.4701−4712
J.Chem.Research(M),1982年,P.1726−1746
Tetrahedron,1987年,Vol.43,No.14,P.3295−3302

Also Published As

Publication number Publication date
JPH0710880A (en) 1995-01-13

Similar Documents

Publication Publication Date Title
HRP20000295A2 (en) Process for the preparation of a new finasteride
JP2002338516A (en) Method of production for 2-halogenated benzoic acids
JPS5834474B2 (en) Method for producing thiazolidine derivatives
WO2006021974A1 (en) A process for synthesizing diol (viii)-an intermediate of montelukast sodium
JP2008174547A (en) Manufacturing method of intermediate of asenapine systhesis
JPH05246980A (en) Beta-oxo-beta-benzenepropanethioamide derivative
US20050245750A1 (en) Process for preparing 1,3-benzodioxole-2-spirocycloalkane derivative
JPH0583550B2 (en)
JP3332171B2 (en) Method for producing thieno [3,2-b] pyridine derivative
NO179517B (en) Process for the preparation of 8-chloroquinolone derivatives
JP3251713B2 (en) Method for producing N-thienylaminomethyleneacetic acid derivative
JP2831000B2 (en) (2-aminobenzoyl) acetic acid ester derivative
JPS5821626B2 (en) The best way to get started
JP3020040B2 (en) Method for producing 2-oxo-5-hydroxychroman
JP2004231521A (en) Method for synthesizing 3-chloro-5-nitrotoluene
JPH0812658A (en) Production of sydnones
JP3523874B2 (en) Quinolone disulfide as an intermediate
JP2816778B2 (en) Method for producing quinazolinone derivatives
US4156728A (en) 3-Substituted-2(1H)pyridone-6-carboxylic acids
JPS5852995B2 (en) Method for producing furfural derivatives
JPH0681744B2 (en) Method for producing 2,4-dioxyquinoline derivative
JPS5951534B2 (en) Method for producing 2-amino-3-hydroxypyridine derivative
JP2640622B2 (en) Method for producing progourmetasin
JPS58192874A (en) Novel spiroisoxazoline derivative
JP4449211B2 (en) 6- (1-fluoroethyl) -5-iodo-4-pyrimidone and process for producing the same

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090726

Year of fee payment: 7

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090726

Year of fee payment: 7

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100726

Year of fee payment: 8

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100726

Year of fee payment: 8

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100726

Year of fee payment: 8

R371 Transfer withdrawn

Free format text: JAPANESE INTERMEDIATE CODE: R371

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100726

Year of fee payment: 8

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110726

Year of fee payment: 9

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120726

Year of fee payment: 10

LAPS Cancellation because of no payment of annual fees